AI Is Ready To Impact Clinical Trials

Artificial Intelligence (AI) is making its way into the realm of clinical trials. While most of the talk I hear seems to center on clinical trial recruitment and using AI to mine electronic medical records (EHRs), that application seems to only scratch the surface. Experts predict monitoring drug adherence, pre-emptive risk monitoring, decision-making, diagnostics, and process optimization are other areas where the technology is expected to make an impact. By the middle of 2020, the AI market for healthcare is expected to top $35 billion, and big names such as Microsoft, Google, and IBM are already collaborating with top universities to further AI. We engaged experts from four of the largest companies in the industry to provide insights on the implementation of AI in clinical trials and the challenges companies are facing.